skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:066515/0036   Pages: 9
Recorded: 02/21/2024
Attorney Dkt #:2272177 PAT
Conveyance: SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).
Total properties: 24
1
Patent #:
8637566
Issue Dt:
01/28/2014
Application #:
13509739
Filing Dt:
05/14/2012
Publication #:
US20120245214
Pub Dt:
09/27/2012
Title:
SLOW INFUSION OF SULCARDINE AND ITS SALTS
2
Patent #:
8541464
Issue Dt:
09/24/2013
Application #:
13509752
Filing Dt:
05/14/2012
Publication #:
US20120309810
Pub Dt:
12/06/2012
Title:
TREATMENT OF ATRIAL FIBRILLATION
3
Patent #:
10385131
Issue Dt:
08/20/2019
Application #:
15592929
Filing Dt:
05/11/2017
Publication #:
US20170327583
Pub Dt:
11/16/2017
Title:
COMBINATION THERAPIES OF HDAC INHIBITORS AND PD-L1 INHIBITORS
4
Patent #:
10385130
Issue Dt:
08/20/2019
Application #:
15592988
Filing Dt:
05/11/2017
Publication #:
US20170327582
Pub Dt:
11/16/2017
Title:
COMBINATION THERAPIES OF HDAC INHIBITORS AND PD-1 INHIBITORS
5
Patent #:
NONE
Issue Dt:
Application #:
15676905
Filing Dt:
08/14/2017
Publication #:
US20190046513
Pub Dt:
02/14/2019
Title:
COMBINATION THERAPIES OF HDAC INHIBITORS AND TUBULIN INHIBITORS
6
Patent #:
10287353
Issue Dt:
05/14/2019
Application #:
16103865
Filing Dt:
08/14/2018
Publication #:
US20180355042
Pub Dt:
12/13/2018
Title:
COMBINATION THERAPIES OF HDAC INHIBITORS AND PD-1 INHIBITORS
7
Patent #:
NONE
Issue Dt:
Application #:
16541007
Filing Dt:
08/14/2019
Publication #:
US20200172621
Pub Dt:
06/04/2020
Title:
COMBINATION THERAPIES OF HDAC INHIBITORS AND PD-1 INHIBITORS
8
Patent #:
11535670
Issue Dt:
12/27/2022
Application #:
16541020
Filing Dt:
08/14/2019
Publication #:
US20200181267
Pub Dt:
06/11/2020
Title:
COMBINATION THERAPIES OF HDAC INHIBITORS AND PD-L1 INHIBITORS
9
Patent #:
11364223
Issue Dt:
06/21/2022
Application #:
16712677
Filing Dt:
12/12/2019
Publication #:
US20200188357
Pub Dt:
06/18/2020
Title:
SULCARDINE ADMINISTRATION FOR TREATMENT OF ACUTE ATRIAL FIBRILLATION
10
Patent #:
11426382
Issue Dt:
08/30/2022
Application #:
16775142
Filing Dt:
01/28/2020
Publication #:
US20200316024
Pub Dt:
10/08/2020
Title:
SULCARDINE SALTS
11
Patent #:
NONE
Issue Dt:
Application #:
16894532
Filing Dt:
06/05/2020
Publication #:
US20200383961
Pub Dt:
12/10/2020
Title:
TRIPLET THERAPIES OF HDAC INHIBITORS, PD-L1 AND/OR PD-1 INHIBITORS, AND CTLA-4 INHIBITORS
12
Patent #:
11020374
Issue Dt:
06/01/2021
Application #:
17079347
Filing Dt:
10/23/2020
Publication #:
US20210038568
Pub Dt:
02/11/2021
Title:
SULCARDINE SALTS
13
Patent #:
11813245
Issue Dt:
11/14/2023
Application #:
17345564
Filing Dt:
06/11/2021
Publication #:
US20210386708
Pub Dt:
12/16/2021
Title:
SULCARDINE ADMINISTRATION FOR TREATMENT OF ACUTE ATRIAL FIBRILLATION
14
Patent #:
NONE
Issue Dt:
Application #:
17410459
Filing Dt:
08/24/2021
Publication #:
US20220110924
Pub Dt:
04/14/2022
Title:
METHODS AND COMPOSITIONS FOR GENETIC MODULATION OF TUMOR MICROENVIRONMENTS
15
Patent #:
NONE
Issue Dt:
Application #:
17736869
Filing Dt:
05/04/2022
Publication #:
US20220370456
Pub Dt:
11/24/2022
Title:
COMBINATION THERAPIES COMPRISING SHP2 INHIBITORS AND EGFR TYROSINE KINASE INHIBITORS
16
Patent #:
NONE
Issue Dt:
Application #:
17736879
Filing Dt:
05/04/2022
Publication #:
US20220370457
Pub Dt:
11/24/2022
Title:
COMBINATION THERAPIES COMPRISING SHP2 INHIBITORS AND PD-1 INHIBITORS
17
Patent #:
NONE
Issue Dt:
Application #:
17736908
Filing Dt:
05/04/2022
Publication #:
US20220370458
Pub Dt:
11/24/2022
Title:
SHP2 INHIBITOR MONOTHERAPY AND USES THEREOF
18
Patent #:
11883380
Issue Dt:
01/30/2024
Application #:
17750944
Filing Dt:
05/23/2022
Publication #:
US20220280480
Pub Dt:
09/08/2022
Title:
SULCARDINE ADMINISTRATION FOR TREATMENT OF ACUTE ATRIAL FIBRILLATION
19
Patent #:
NONE
Issue Dt:
Application #:
17862117
Filing Dt:
07/11/2022
Publication #:
US20220356319
Pub Dt:
11/10/2022
Title:
SULCARDINE SALTS
20
Patent #:
NONE
Issue Dt:
Application #:
17993567
Filing Dt:
11/23/2022
Publication #:
US20230151099
Pub Dt:
05/18/2023
Title:
COMBINATION THERAPIES OF HDAC INHIBITORS AND PD-L1 INHIBITORS
21
Patent #:
NONE
Issue Dt:
Application #:
18120311
Filing Dt:
03/10/2023
Publication #:
US20230293539
Pub Dt:
09/21/2023
Title:
MLL1-WDR5 PROTEIN-PROTEIN INTERACTION INHIBITOR COMPOUNDS AND USES THEREOF
22
Patent #:
NONE
Issue Dt:
Application #:
18120318
Filing Dt:
03/10/2023
Publication #:
US20230286925
Pub Dt:
09/14/2023
Title:
PHENYL TRIAZOLE MLL1-WDR5 PROTEIN-PROTEIN INTERACTION INHIBITOR
23
Patent #:
NONE
Issue Dt:
Application #:
18120326
Filing Dt:
03/10/2023
Publication #:
US20230286948
Pub Dt:
09/14/2023
Title:
HALOALKYLPYRIDYL TRIAZOLE MLL1-WDR5 PROTEIN-PROTEIN INTERACTION INHIBITOR
24
Patent #:
NONE
Issue Dt:
Application #:
18484823
Filing Dt:
10/11/2023
Publication #:
US20240058304
Pub Dt:
02/22/2024
Title:
SULCARDINE ADMINISTRATION FOR TREATMENT OF ACUTE ATRIAL FIBRILLATION 94919.0739.717301US
Assignor
1
HUYABIO INTERNATIONAL, LLC
Exec Dt:
02/20/2024
Assignee
1
R-BRIDGE INVESTMENT SIX PTE. LTD.
88 MARKET STREET
#46-04/05 CAPITASPRING
SINGAPORE, SINGAPORE 048948
Correspondence name and address
STEWART WALSH
1025 CONNECTICUT AVE NW, SUITE 712
COGENCY GLOBAL INC.
WASHINGTON, DC 20036

Search Results as of: 06/06/2024 03:50 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT